Lori K Davis, Nancy Visitacion, Larry G Riley, Naoshi Hiramatsu, Craig V Sullivan, Tetsuya Hirano, E Gordon Grau
Index: Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 149(4) , 507-14, (2009)
Full Text: HTML
Effects of two endocrine disruptors, o,p'-DDE and heptachlor, and 17beta-estradiol (E(2)) on vitellogenin (Vg) and the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis were examined in male tilapia. In the first experiment, fish were given 5 weekly injections of either E(2), o,p'-DDE or heptachlor (5 microg/g). E(2) treatment increased plasma Vg and hepatic expression of three Vg genes (Vgs A, B, and C) and estrogen receptor alpha (ERalpha), while reducing plasma levels of IGF-I and suppressing the expression of IGF-I, the GH receptor (GHR2) and the putative somatolactin receptor (GHR1). Neither pesticide greatly affected the other parameters examined, except for a significant reduction in expression of GHR2 and increased plasma IGF-I. In the second experiment, fish were given a single injection of o,p'-DDE or heptachlor (100 microg/g), or E(2) (5 microg/g) and sacrificed 5 days post-injection. Treatment with E(2) stimulated expression of all three Vg genes. Both o,p'-DDE and heptachlor increased expression of VgB, whereas only o,p'-DDE increased VgA expression. There was no effect of o,p'-DDE or heptachlor on VgC expression or plasma Vg levels. Treatment with o,p'-DDE and heptachlor as well as E(2) increased ERalpha and ERbeta transcript levels. Similarly, both pesticides increased GHR1 and IGF-I expression, whereas no significant effect of E(2) was observed on GHR1, GHR2 or IGF-I expression. These results indicate that o,p'-DDE and heptachlor have varying temporal and dose effects on modulation of Vg and the GH/IGF-I axis that are distinct from E(2).
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
o,p'-dde
CAS:3424-82-6 |
C14H8Cl4 |
Organochlorine pesticides and polychlorinated biphenyls in s...
2012-03-01 [Ecotoxicol. Environ. Saf. 77 , 35-44, (2012)] |
DDT- and DDE-induced disruption of ovarian steroidogenesis i...
2007-12-01 [J. Physiol. Pharmacol. 58(4) , 873-85, (2007)] |
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as pr...
2011-06-01 [J. Clin. Endocrinol. Metab. 96(6) , 1844-51, (2011)] |
Detection of endocrine disrupting chemicals in samples of se...
2000-08-01 [J. Clin. Endocrinol. Metab. 85(8) , 2954-7, (2000)] |
Plasma level monitoring of mitotane (o,p'-DDD) and its metab...
1991-01-01 [Eur. J. Clin. Pharmacol. 41(3) , 259-61, (1991)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved